Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B



Status:Terminated
Conditions:Hematology
Therapuetic Areas:Hematology
Healthy:No
Age Range:18 - Any
Updated:11/16/2018
Start Date:December 16, 2015
End Date:October 18, 2017

Use our guide to learn which trials are right for you!

Phase I/II Open-Label Safety and Dose Finding Study of Adeno-Associated Virus (AAV) rh10-Mediated Gene Transfer of Human Factor IX in Adults With Moderate/Severe to Severe Hemophilia B

A Phase 1/2, open-label, dose-finding safety study of single ascending doses of DTX101 in
adult males with moderate/severe to severe hemophilia B.

Hemophilia B is an X-linked recessive genetic bleeding disorder caused by mutations in the
factor IX (FIX) gene. FIX is produced in the liver and is critical for fibrin clot formation.
Hemophilia B is characterized by frequent, spontaneous internal bleeding that can lead to
chronic arthropathy (joint damage), intracranial hemorrhage, and even death. In patients with
moderate/severe to severe hemophilia B, the majority of bleeding episodes occur in the joints
and, if not treated, lead to debilitating damage and a decreased quality of life.

This study will evaluate the safety and efficacy of the adeno-associated virus (AAV) to
deliver human factor IX (hFIX) gene, the healthy gene necessary to make FIX, to the liver
where FIX is normally produced. This study will determine if AAVrh10 can produce clinically
meaningful FIX levels in patients with moderately/severe or severe hemophilia B.

This study was previously posted by Dimension Therapeutics, which has been acquired by
Ultragenyx in November 2017.

Inclusion Criteria:

1. Male ≥ 18 years of age.

2. Moderate/severe or severe hemophilia B (baseline FIX activity ≤ 2% of normal or
documented history of FIX activity ≤2%).

3. At least 3 bleeding episodes per year that require on-demand treatment with FIX OR are
treated with a prophylactic regimen of FIX.

4. At least 100 days exposure history to FIX.

5. No documented history of inhibitors (neutralizing antibodies) to exogenous FIX.

6. No known allergic reaction to exogenous FIX or any component of DTX101.

7. Willing to stop prophylactic treatment with recombinant FIX at specified time points
during the study.

Exclusion Criteria:

1. History of significant liver disease (ie, portal hypertension).

2. Significant hepatic inflammation or cirrhosis.

3. Evidence of active hepatitis B virus (HBV) or hepatitis C virus (HCV) infection.

4. History of human immunodeficiency virus (HIV) infection AND any of the following: CD4+
cell count < 350 cells/mm^3, change in antiretroviral therapy regimen within 6 months
prior to Day 0, or plasma viral load > 200 copies/mL, on 2 separate occasions, as
measured by polymerase chain reaction.

5. Anti-AAVrh10 neutralizing antibody titer > 1:5.

6. Participation (current or previous) in another gene therapy study.

7. Participation in another investigational medicine study within 3 months before
screening.

NOTE: Other protocol defined inclusion/exclusion criteria may apply.
We found this trial at
7
sites
300 Longwood Ave
Boston, Massachusetts 02115
(617) 355-6000
Boston Children's Hospital Boston Children's Hospital is a 395-bed comprehensive center for pediatric health care....
?
mi
from
Boston, MA
Click here to add this to my saved trials
Gainesville, Florida 32610
(352) 392-3261
University of Florida The University of Florida (UF) is a major, public, comprehensive, land-grant, research...
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
1 Children's Way
Little Rock, Arkansas 72202
(501) 364-1100
Arkansas Children's Hospital Arkansas Children's Hospital (ACH) is the only pediatric medical center in Arkansas...
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
Los Angeles, California 90007
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Nashville, Tennessee 37232
?
mi
from
Nashville, TN
Click here to add this to my saved trials
?
mi
from
Sofia,
Click here to add this to my saved trials